Pyrimethamine — Drug Intelligence | 2 EU Trials

Filter these 2 trials by condition, phase, country and more.

2 Registered trials

0 Recruiting

1 Completed trials

1 Sponsors

1 Countries

Phase II

Phase II: 2

Sponsors using this IMP

2 total

PLUTO Pending

2026-525211-14-00 Phase II 1 country Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Optimizing reversal of HIV latency with combination therapy (pyrimethamine, lenalidomide, panobinostat) Ended

2024-511192-15-00 Phase II 1 country Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Showing 1–2 of 2 trials